Bristol-Myers Squibb Co. (BMY)

49.85
0.38 0.77
NYSE : Health Technology
Prev Close 49.47
Open 49.49
Day Low/High 49.35 / 50.08
52 Wk Low/High 42.48 / 63.69
Volume 4.10M
Avg Volume 12.58M
Exchange NYSE
Shares Outstanding 1.64B
Market Cap 81.15B
EPS 3.00
P/E Ratio 12.66
Div & Yield 1.64 (3.29%)

Some Afternoon Observations

* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF  has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...

Here's What's Up This A.M.

The Nasdaq (QQQs) turn slightly negative as most of the FANGs reverse lower.   Retail, generics (Teva and Mylan ), big pharma (Merck and Bristol-Myers Squibb ) and biotech (Allergan , Gilead Sciences , Celgene ) are conspicuous to the downside.   Co...

Notable Movements

In terms of sector price movement today: * FANGs continue to extend recent gains.  * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...

Bristol-Myers Squibb Bulls Take a Short Break

Bristol-Myers Squibb Bulls Take a Short Break

There is strong support just below the market for drug giant.

Cramer: We're Seeing the Best of Times and the Worst of Times at the Same Time

Cramer: We're Seeing the Best of Times and the Worst of Times at the Same Time

It depends on which aisle of the stock market you're on.

Two-Sided Market

An observation:  Despite being within 1% of the all-time high in the S&P Index, this week's feature was a number of investment potholes --relatively large sized individual fundamental disappointments followed by marked stock price drops. Celgene , B...

Cramer: Stock Market's 'Safety Dance' Has Reversed

Cramer: Stock Market's 'Safety Dance' Has Reversed

What was dangerous is now safe, what was safe is now risky.

Remember That Bumps in the Road Are Normal: Market Recon

Remember That Bumps in the Road Are Normal: Market Recon

The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.

My Takeaways and Observations

There's something happening here What it is ain't exactly clear There's a man with a gun over there Telling me I got to beware -- Buffalo Springfield, For What Its Worth Few longs meet my standards and I now believe risk exceeds reward (S&P kind) by...

Cramer: What's Tax Reform Got to Do With It?

Cramer: What's Tax Reform Got to Do With It?

Treasury secretary says it's baked into the market, but is anyone really counting on it?

Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer

Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer

Investors rolled into shares of Apple in September, according to TD Ameritrade, but took profits on shares of Bristol-Myers and Pfizer shares.

Video: Jim Cramer on the Jobs Report, Costco, Disney, Netflix and Nvidia

Video: Jim Cramer on the Jobs Report, Costco, Disney, Netflix and Nvidia

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks including Costco, Disney, Netflix and Nvidia.

Watch: Jim Cramer Reveals His Outlook for Eli Lilly and Bristol Myers

Watch: Jim Cramer Reveals His Outlook for Eli Lilly and Bristol Myers

Eli Lilly is a holding of Jim Cramer's charitable trust, Action Alerts PLUS.

Positive Signs in Drug Distribution

Positive Signs in Drug Distribution

Blockbuster drugs still need companies to deliver them.

Cramer: Is There a Human Element to This Rally?

Cramer: Is There a Human Element to This Rally?

It could be all machine-to-machine and not much more than that.

Time to Adjust as Bristol-Myers Squibb Continues Its Climb

Time to Adjust as Bristol-Myers Squibb Continues Its Climb

It just keeps going higher.

There Are Good Opportunities in Stock Picking

There Are Good Opportunities in Stock Picking

The indices may need a rest, but stock-pickers have an edge.

Bristol-Myers Squibb Is Primed for an Upside Breakout

Bristol-Myers Squibb Is Primed for an Upside Breakout

Prices have test $60 several times, but this looks like the real deal.

Cramer: Good News Stirs a Sneaky Rally

Cramer: Good News Stirs a Sneaky Rally

We are also seeing some stocks that are just too strong for their own good.

Taking Bristol-Myers Trade off the Table

Taking Bristol-Myers Trade off the Table

Our strategy has captured some time decay on the short call and a lift on the long call side.

The Market Band Plays On, but You Won't Catch Me Humming Its Mindless Tune

The Market Band Plays On, but You Won't Catch Me Humming Its Mindless Tune

The market's issues run deep and my concerns about its health are based on both technical and fundamental grounds.

The Band Is Playing On, but I Still Don't Like the Tune

* In a paperless and cloudy world, are investors and citizens as safe as the markets assume we are? --Kass Diary Throughout the last six months I have expressed the view that the S&P 500 Index was in the process of making an important top and that r...

Cramer: This Could Be the End of Trump's Alternate Facts Narrative

Cramer: This Could Be the End of Trump's Alternate Facts Narrative

What do you get from participation with the president, if the president doesn't represent the country's values?

A Roundup of My Open Positions

A Roundup of My Open Positions

Buying back Square puts and changing my trade on Target.

Jim Cramer Reveals Why Drug Stocks Don't Go On Sale Anymore

Jim Cramer Reveals Why Drug Stocks Don't Go On Sale Anymore

Cramer's outlook on drug stocks.

Capturing Profits on AIG

Capturing Profits on AIG

Let's roll with the sure thing and not wait for expiry.

In Good Company on Bristol-Myers

In Good Company on Bristol-Myers

Move over, Helene, I'm getting in on what appears to be a breakout.

Cramer: Why I Spent My Weekend Defending the Bull Market

Cramer: Why I Spent My Weekend Defending the Bull Market

I've heard all of the bearish arguments, but I don't believe them.

Intermediate Trade: Bristol-Myers Squibb

Intermediate Trade: Bristol-Myers Squibb

The trade is the out-of-the-money, bullishly biased vertical call spread expiring in August.